Basal or stimulated thyroglobulin in evaluating response to treatment in papillary thyroid carcinoma? A retrospective cohort study.
Leticia BarretoDeborah Cristina Goulart FerreiraJose Eduardo CorrenteCarlos Segundo Paiva SoaresCristiano Claudino OliveiraSimone Antunes TerraSonia Marta MoriguchiKatia Hiromoto KogaJosé Vicente TagliariniGláucia Maria Ferreira da Silva MazetoPublished in: Hormones (Athens, Greece) (2023)
Response to therapy at 1 year using STg was altered in approximately 20% of cases and therefore proved to be a better predictor of excellent response in the last evaluation.